Literature DB >> 11742144

Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs.

N M Rupniak1, E J Carlson, J K Webb, T Harrison, R D Porsolt, S Roux, C de Felipe, S P Hunt, B Oates, A Wheeldon.   

Abstract

The phenotype of NK1R-/- mice was compared with that of acute pharmacological blockade of the tachykinin NK1 receptor on sensorimotor function and in assays relevant to depressive illness and anxiety. The dose range for L-760735 and GR205171 that was associated with functional blockade of central NK1 receptors in the target species was established by antagonism of the behavioural effects of intracerebroventricular NK1 agonist challenge in gerbils, mice and rats. The caudal grooming and scratching response to GR73632 was absent in NK1R-/- mice, confirming that the receptor had been genetically ablated. There was no evidence of sedation or motor impairment in NK1R-/- mice or following administration of L-760735 to gerbils, even at doses in excess of those required for central NK1 receptor occupancy. In the resident-intruder and forced swim test, the behaviour of NK1R-/- mice, or animals treated acutely with L-760735 or GR205171, resembled that seen with the clinically used antidepressant drug fluoxetine. However, the effects of GR205171 were not clearly enantioselective in mice. In contrast, although NK1R-/- mice also exhibited an increase in the duration of struggle behaviour in the tail suspension test, this was not observed following pharmacological blockade with L-760735 in gerbils or GR205171 in mice, suggesting that this may reflect a developmental alteration in the knockout mouse. There was no effect of NK1 receptor blockade with L-760735 in guinea-pigs or GR205171 in rats, or deletion of the NK1 receptor in mice, on behaviour in the elevated plus-maze test for anxiolytic activity. These findings extend previous observations on the phenotype of the NK1R-/- mouse and establish a broadly similar profile following acute pharmacological blockade of the receptor. These studies also serve to underscore the limitations of currently available antagonists that are suitable for use in rat and mouse behavioural assays.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742144     DOI: 10.1097/00008877-200111000-00011

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  26 in total

1.  Chronic psychosocial stress in tree shrews: effect of the substance P (NK1 receptor) antagonist L-760735 and clomipramine on endocrine and behavioral parameters.

Authors:  Marieke G C van der Hart; Gabriel de Biurrun; Boldizsár Czéh; Nadia M J Rupniak; Johan A den Boer; Eberhard Fuchs
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

Review 2.  Translational and reverse translational research on the role of stress in drug craving and relapse.

Authors:  Rajita Sinha; Yavin Shaham; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

Review 3.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  The autism diagnosis in translation: shared affect in children and mouse models of ASD.

Authors:  Somer L Bishop; Garet P Lahvis
Journal:  Autism Res       Date:  2011-08-31       Impact factor: 5.216

5.  [3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain.

Authors:  Cristiana Griffante; Renzo Carletti; Filippo Andreetta; Mauro Corsi
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

6.  Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice.

Authors:  Annika Thorsell; Jesse R Schank; Erick Singley; Stephen P Hunt; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2010-01-30       Impact factor: 4.530

7.  Using the rat forced swim test to assess antidepressant-like activity in rodents.

Authors:  David A Slattery; John F Cryan
Journal:  Nat Protoc       Date:  2012-05-03       Impact factor: 13.491

8.  Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism.

Authors:  J E Robinson; E W Fish; M C Krouse; A Thorsell; M Heilig; C J Malanga
Journal:  Psychopharmacology (Berl)       Date:  2011-09-10       Impact factor: 4.530

9.  Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition.

Authors:  Petra C Arck; Bori Handjiski; Arne Kuhlmei; Eva M J Peters; Maike Knackstedt; Anita Peter; Stephen P Hunt; Burghard F Klapp; Ralf Paus
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

Review 10.  Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.

Authors:  Markus Heilig; Annika Thorsell; Wolfgang H Sommer; Anita C Hansson; Vijay A Ramchandani; David T George; Daniel Hommer; Christina S Barr
Journal:  Neurosci Biobehav Rev       Date:  2009-11-24       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.